Prosecution Insights
Prosecution Insights
9 pending office actions • 6 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (22%) |
| §103 only | 2 (22%) |
| Double-patenting only | 1 (11%) |
| Double-patenting + other | 2 (22%) |
| Multi-statute (no §101) | 2 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AHMED, SAMIR ANWAR | 1 | 87.8% | +12.4% |
| JASANI, ASHISH SHIRISH | 1 | 68.7% | +24.5% |
| ROCHELLE, CIERRA MARIE | 1 | — | — |
| JOHANSEN, PETER N. | 1 | 58.9% | +24.3% |
| BENAVIDES, JENNIFER ANN | 1 | 51.3% | +48.6% |
| JUEDES, AMY E | 1 | 45.0% | +41.4% |
| XIAO, YAN | 1 | 67.8% | +51.6% |
| FONSECA LOPEZ, FRANCINI ALVARENGA | 1 | 33.3% | +44.4% |
| LEE, HOI YAN NMN | 1 | 41.0% | +79.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18856807 | MULTI-MODAL MACHINE LEARNING TO DETERMINE RISK STRATIFICATION | AHMED, SAMIR ANWAR | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18325912 | METHODS FOR TREATING MISMATCH REPAIR DEFICIENT LOCALLY ADVANCED RECTAL CANCER USING DOSTARLIMAB | XIAO, YAN | 9d |
| 17857821 | SYSTEMS AND METHODS FOR CANCER WHOLE GENOME AND TRANSCRIPTOME SEQUENCING (CWGTS) | FONSECA LOPEZ, FRANCINI ALVARENGA | 15d |
| 18856763 | AUTOMATED METHODS FOR DETERMINING FIBROGLANDULAR DENSITY ON MAMMOGRAMS | JASANI, ASHISH SHIRISH | 33d |
| 18554176 | METHODS FOR INHIBITING KRAS ONCOPROTEIN THROUGH ENHANCED GTPASE ACTIVITY | JOHANSEN, PETER N. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18325912 | METHODS FOR TREATING MISMATCH REPAIR DEFICIENT LOCALLY ADVANCED RECTAL CANCER USING DOSTARLIMAB | XIAO, YAN | 9d |
| 17857821 | SYSTEMS AND METHODS FOR CANCER WHOLE GENOME AND TRANSCRIPTOME SEQUENCING (CWGTS) | FONSECA LOPEZ, FRANCINI ALVARENGA | 15d |
| 18856763 | AUTOMATED METHODS FOR DETERMINING FIBROGLANDULAR DENSITY ON MAMMOGRAMS | JASANI, ASHISH SHIRISH | 33d |
| 18856807 | MULTI-MODAL MACHINE LEARNING TO DETERMINE RISK STRATIFICATION | AHMED, SAMIR ANWAR | — |
| 18554176 | METHODS FOR INHIBITING KRAS ONCOPROTEIN THROUGH ENHANCED GTPASE ACTIVITY | JOHANSEN, PETER N. | — |
| 18554184 | COMBINATION THERAPY WITH DEXAMETHASONE AND TUMOR-SPECIFIC T CELL ENGAGING MULTI-SPECIFIC ANTIBODIES FOR TREATING CANCER | BENAVIDES, JENNIFER ANN | — |
| 18550914 | METHODS FOR TREATING GYNECOLOGIC CANCER USING COMBINATION THERAPY WITH ANTI-MUC16 x CD3 MULTISPECIFIC ANTIBODIES AND VEGF INHIBITORS | JUEDES, AMY E | — |
| 17427502 | DEUTERATED MITRAGYNINE ANALOGS AS SAFER OPIOID MODULATORS IN THE MITRAGYNINE CLASS | LEE, HOI YAN NMN | — |
| Art Unit | Apps |
|---|---|
| 1644 | 2 |
| 3798 | 1 |
| 1675 | 1 |
| 1642 | 1 |
| 1685 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18856807 | MULTI-MODAL MACHINE LEARNING TO DETERMINE RISK STRATIFICATION | AHMED, SAMIR ANWAR | — | §103 | Non-Final OA | — | Pending | Oct 14, 2024 |
| 18856763 | AUTOMATED METHODS FOR DETERMINING FIBROGLANDULAR DENSITY ON MAMMOGRAMS | JASANI, ASHISH SHIRISH | 3798 | §102§103 | Final Rejection | 33d | Pending | Oct 14, 2024 |
| 18840416 | METHODS FOR TREATING CANCER PATIENTS WITH HOMOLOGOUS RECOMBINATION DEFICIENCY BASED ON TEMPLATED INSERTIONS | ROCHELLE, CIERRA MARIE | — | §103 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18554176 | METHODS FOR INHIBITING KRAS ONCOPROTEIN THROUGH ENHANCED GTPASE ACTIVITY | JOHANSEN, PETER N. | 1644 | §101§112 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18554184 | COMBINATION THERAPY WITH DEXAMETHASONE AND TUMOR-SPECIFIC T CELL ENGAGING MULTI-SPECIFIC ANTIBODIES FOR TREATING CANCER | BENAVIDES, JENNIFER ANN | 1675 | DP | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18550914 | METHODS FOR TREATING GYNECOLOGIC CANCER USING COMBINATION THERAPY WITH ANTI-MUC16 x CD3 MULTISPECIFIC ANTIBODIES AND VEGF INHIBITORS | JUEDES, AMY E | 1644 | §102§103§112DP | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18325912 | METHODS FOR TREATING MISMATCH REPAIR DEFICIENT LOCALLY ADVANCED RECTAL CANCER USING DOSTARLIMAB | XIAO, YAN | 1642 | §102§103 | Non-Final OA | 9d | Pending | May 30, 2023 |
| 17857821 | SYSTEMS AND METHODS FOR CANCER WHOLE GENOME AND TRANSCRIPTOME SEQUENCING (CWGTS) | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§103§112 | Non-Final OA | 15d | Pending | Jul 05, 2022 |
| 17427502 | DEUTERATED MITRAGYNINE ANALOGS AS SAFER OPIOID MODULATORS IN THE MITRAGYNINE CLASS | LEE, HOI YAN NMN | 1693 | §103DP | Final Rejection | — | Pending | Jul 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial